Bespoke Extracts (BSPK) Accounts Payables (2011 - 2025)
Bespoke Extracts (BSPK) reported Accounts Payables of $1.4 million for Q3 2025, down 3.74% on a YoY basis from $1.4 million in Q3 2024, and up 3.62% sequentially from $1.3 million in Q2 2025.
Bespoke Extracts (BSPK) Accounts Payables (2011 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 15 years of Accounts Payables data on file, last reported at $1.4 million in Q3 2025.
- For the quarter ending Q3 2025, Accounts Payables fell 3.74% year-over-year to $1.4 million; the trailing twelve-month figure through Sep 2025 stood at $1.4 million (down 3.74% YoY), and the FY2024 full-year result was $958276.0, changed 0.31% from the prior year.
- Accounts Payables grew to $1.4 million in Q3 2025, from $1.3 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $1.4 million in Q3 2024 to a low of $42228.0 in Q3 2021.
- A 5-year average of $668914.3 and a median of $647884.0 in 2023 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables tumbled 53.4% in 2021 and soared 365.89% in 2023, its largest moves.
- Tracing BSPK's Accounts Payables over 5 years: stood at $46830.0 in 2021, then jumped by 531.68% to $295818.0 in 2022, then soared by 224.95% to $961255.0 in 2023, then retreated by 0.31% to $958276.0 in 2024, then jumped by 45.35% to $1.4 million in 2025.
- Business Quant data shows BSPK's Accounts Payables at $1.4 million in Q3 2025, $1.3 million in Q2 2025, and $1.1 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 958,276.00 |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 961,255.00 |
| Sep 30, 2023 | 828,069.00 |
| Jun 30, 2023 | 647,884.00 |
| Mar 31, 2023 | 492,074.00 |
| Dec 31, 2022 | 295,818.00 |
| Sep 30, 2022 | 219,841.00 |
| Jun 30, 2022 | 159,022.00 |
| Mar 31, 2022 | 105,621.00 |
| Nov 30, 2021 | 46,830.00 |
| Aug 31, 2021 | 42,228.00 |
| May 31, 2021 | 62,136.00 |
| Feb 28, 2021 | 115,928.00 |
| Nov 30, 2020 | 100,484.00 |